Wikipedia -WSS

Wikipedia

author：fashion 2025-09-29 09:29:54 - browse：892

Sarepta - Cambridge -AP — A logo sign outside of the headquarters of Sarepta Therapeutics in Cambridge, Mass. Kristoffer Tripplaar/Sipa via AP

Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to intervene earlier this year, according to three people with direct knowledge of the agency deliberations.

Inside the FDA office that oversees gene therapies, some staff had reached a non-binding conclusion that Sarepta’s gene therapy should be rejected, the individuals said, speaking on condition of anonymity. Peter Marks, a top FDA official and vocal advocate for faster gene therapy approvals, stepped in and directed staff to schedule a public hearing on the therapy on May 12.

Sarepta announced the scheduling of the public hearing last month, but the internal deliberations that led to it have not been previously reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Eli Lilly reports tirzepatide MASH success during Q4 earnings

focus

WSS

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

New chief aims to remake Sanofi Genzyme

Trump Organization, Michael Cohen agree to settle million

STAT Boddities: What happens to the brain when we get scared?

What is the Turing Test that determines if computers can think?

Doctors on social media are being harassed and cyberbullied

Wikipedia

Wikipedia

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Medicare proposal to cover medical devices draws a mixed reaction

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Long Covid research funding gets a major boost from NIH

BioMarin wins approval for gene therapy to treat hemophilia A

AMAs digital advisors table RPM coding reform proposal, again

Duchenne breakthrough therapy leaves behind pioneering families

Congress considering partial increase for doctor pay in Medicare

focus

It's time to take a new tack for treating Alzheimer's

It's time to take a new tack for treating Alzheimer's

Doctors on social media are being harassed and cyberbullied

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Ebola vaccine can save some who are already sick, per new study

Congress must protect the remaining independent doctors

focus

entertainment

focus

focus